10.12.2010

Intensive Cooperation

Wake-up Call - Infant formula laced with melamine, heparin tainted with oversulfated chondroitin sulfate, cough syrup contaminated with diethylene glycol - these scandals didn't just cause outrage among consumers over the recent years. They have also served as a wake-up call for both suppliers and manufacturers in the pharmaceutical industry and have made apparent the need for companies on both sides to work together to exchange information.
more16.11.2010

Dr. Karl Kolter of BASF Wins International Research Award

Dr. Karl Kolter, BASF head of Pharmaceutical Excipients Research and Development, was honored at the AAPS Annual Meeting and Exposition with the 2010 International Pharmaceutical Excipients Council Foundation (IPEC) Industry Research Achievement in Excipient Technology. Dr. Kolter received the newly established award in honor of his outstanding history of research into novel pharmaceutical excipients. more15.06.2010

Turning Point

Sharp Focus - 2010 could be a watershed year for the excipient sector in Europe as amendments to the falsified medicines directive bring excipient quality and safety considerations to the fore. As the second decade in the 21st century gets underway, it is a pivotal time for excipient suppliers and users, with greater attention being paid than ever before to the quality and safety of materials used to manufacture pharmaceuticals. more